EXHIBIT 23.2


                        CONSENT OF INDEPENDENT AUDITORS


We consent to the reference to our firm under the caption "Experts" and to the
use of our report dated February 19, 2003 with respect to the financial
statements of Reliant Pharmaceuticals, LLC as of and for the year ended December
31, 2002, included in this Post-Effective Amendment No. 2 to the Registration
Statement No. 333-108483 and related Prospectus of Alkermes, Inc.



/s/ Ernst & Young LLP


MetroPark, New Jersey
October 30, 2003